Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-336-2 | CAS number: 68425-16-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
A reverse gene mutation assay in bacteria (similar to OECD TG 471, GLP; Dawkes, 1998) and a chromosome aberration study (OECD TG 473, GLP; Burman, 1998) with the test substance di-tert-nonyl polysulfide provided negative results. The results of an in vitro gene mutation study in mammalian cells (OECD TG 490, GLP; Charles River Laboratories, 2021) with the test substance di-tert-nonyl polysulfides were negative with and without metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997-11-03 to 1998-07-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- other: Human Lymphocytes
- Metabolic activation:
- with and without
- Test concentrations with justification for top dose:
- 122.5, 175, 250 µg/ml
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMF
- Positive controls:
- yes
- Evaluation criteria:
- The test article is considered as positive in this assay if:
1. a statistically significant increase in the proportion of cells with structural aberrations (excluding gaps) occurs at one or more concentrations, and
2. the proportion of cells with structural aberrations at such doses exceeds normal range - Species / strain:
- lymphocytes: human peripheral blood lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks on result:
- no mutagenic potential (based on QSAR/QSPR prediction)
- Conclusions:
- TPS 37 did not induce chromosome aberrations in cultured human peripheral blood lymphocytes when tested in excess of its limit of solubility in both the absence and presence of S-9.
- Executive summary:
In a chromosome aberration study in mammals, human lymphocyte cultures from female donors were exposed to TPS 37 in DMF at concentrations of 122.5, 175, and 250 µg/mL in the presence and absence of mammalian metabolic activation (S-9 mix) for up to 20 hours.
TPS 37 was tested up to concentrations of 250 µg/mL. Cultures treated with TPS 37 in the absence and presence of S-9 exhibited frequencies of cells with structural aberrations which were similar to levels seen in concurrent negative controls. One culture treated with 122.5 µg/mL for 20 hours in the absence of S-9 displayed frequencies of cells with structural aberrations that exceeded the normal range for negative controls. A replication did not produce similar results so the effect was not considered biologically relevant. All other tests exhibited frequencies of cell that were within the normal range. It is concluded that TPS 37 did not induce chromosome aberrations in cultured human peripheral blood lymphocytes when tested in the presence and absence of S-9 mix.
This study received a Klimisch score of 1 and is classified as reliable without restriction because it provides robust results and carefully follows OECD guidelines.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997-10-31 to 1998-05-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- Cited as Directive 84/449/EEC, B.14
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- OECD GLP
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- histidine
- Species / strain / cell type:
- other: Strains: TA 98, TA 100, TA 1535, TA 1537, TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- Experiment 1: 8, 40, 200, 1000 and 5000 µg/plate
Experiment 2: 4.883, 19.531, 78.125, 312.5, 1250 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMF
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMF
- True negative controls:
- yes
- Positive controls:
- yes
- Remarks:
- DMSO
- Details on test system and experimental conditions:
- SYSTEM OF TESTING
- 2 independent trials; in the 1st and 2nd trial without metabolic activation system (MA) the direct plate incorporation method was used; this method also used in the 1st trial with MA, in the 2nd trial with MA the preincubation method (1 h, 37°C). 3 plates per concentration
- Metabolic activation system (MA): S9 fraction from liver homogenates of rats induced with 500 mg/kg Aroclor 1254
- solvent: dimethylformamide
- Controls: solvent control (with and without MA)
. Positives controls:
- Without S9
TA98: 2-nitrofluorene 5.0 µg/plate
TA100 and TA1535: Sodium azide 2.0 µg/plate
TA1537: 9-aminoacridine 50 µg/plate
TA102: glutaraldehyde 25 µg/plate
- With S9
TA98, TA100 and TA1535: 2-aminoanthracene 5.0 µg/plate
. sterility control checked during the test.
- Concentrations:
Experiment 1: 8, 40, 200, 1000 and 5000 µg/plate
Experiment 2: 4.883, 19.531, 78.125, 312.5, 1250 and 5000 µg/plate
- Cytotoxicity: A preliminary toxicity test was performed to define the concentrations to be used for the mutagenicity study. TA100 exposed to 8-5000 µg/plate with and without MA - Evaluation criteria:
- The test article was considered to be mutagenic if:
1. the assay was valid
2. a dose related and reproducible increase in the number of revertants is observed, or a significant and reproducible increase in the number of revertants was induced at one or more test concentration. - Species / strain:
- other: Strains: TA 98, TA 100, TA 1535, TA 1537, TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: >= 1250 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Evidence of toxicity was observed at >=1250 µg/plate in only a few test strains. Precipitation of test agent was observed on all plates treated at concentrations >= 1000 µg/plate.
The mean numbers of revertant colonies on negative control plates all fell within acceptable ranges, and were significantly elevated by positive control treatments.
No TPS 37 treatment of any of the test strains produced an increase in revertant numbers sufficient to be considered as indicative of mutagenic activity. - Remarks on result:
- no mutagenic potential (based on QSAR/QSPR prediction)
- Conclusions:
- TPS 37 did not induce mutation in five strains of Salmonella typhimurium (TA98, TA100, TA1535, TA1537 and TA102), when tested under the conditions employed for this study, which included treatments up to 5000 µg/plate, both in the absence and in the presence of a rat liver metabolic activation system (S-9).
- Executive summary:
In a reverse gene mutation assay in bacteria, strains TA98, TA100, TA1535, TA1537 and TA102 of S. typhimurium were exposed to TPS 37 in DMF at concentrations of 8, 40, 200, 1000, and 5000 µg/plate in the presence and absence of mammalian metabolic activation using the Ames test.
TPS 37 was tested up to limit concentrations of 5000 µg/plate. Following treatment in experiment 1, evidence of toxicity was observed at the highest dose (5000 µg/plate) treatments in only a few test strains. Precipitation of test agent was observed on all plates treated at concentrations of 1000 and 5000 µg/plate. For experiment 2, dose intervals were narrowed to more closely investigate those concentrations of TPS 37 most likely to induce mutagenic response. All treatments in the presence of S-9 employed a pre-incubation step. Evidence of toxicity was found in the higher test doses in the presence and absence of S-9 mix. Precipitation of test agent was observed on all plates at concentrations of 1250 and 5000 µg/plate. No treatment with TPS 37 of any test strains produced an increase in revertant numbers high enough to be considered characteristic of mutagenic activity. TPS 37 did not induce mutation in five strains of S. typhimurium when tested under study conditions. Conditions included treatments up to 5000 µg/plate and the absence and presence of rat liver activation system.
This study received a Klimisch score of 1 and is classified as reliable without restrictions because it adheres to guidelines and includes testing at the limiting concentration.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 January 2021 - 09 March 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Target gene:
- Thymidine kinase
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Remarks:
- TK+/--3.7.2C
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : phenobarbital (80 mg/kg body weight) and ß-naphthoflavone (100 mg/kg) induced rat liver S9 obtained from Trinova Biochem GmbH, Giessen, Germany.
- method of preparation of S9 mix: 0.5 mL S9-fraction added to 0.5 mL S9 components which contained per mL physiological saline: 1.63 mg MgCl2.6H2O; 2.46 mg KCl; 1.7 mg glucose-6-phosphate; 3.4 mg NADP; 4 μmol HEPES, filter sterilised.
- concentration or volume of S9 mix and S9 in the final culture medium: 4% (v/v).
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): no information - Test concentrations with justification for top dose:
- 6.3, 13, 25, 50, 100, 200, 400, 600, 800, 1000 and 1250 μg/mL
based on the dose range finding test and rejected first experiment (maximum dose in first experiment was too low). After 3 hours, the test item precipitated in the test system at concentrations of 600 μg/mL and above. The test item was not toxic and difficult to dissolve in aqueous solutions for the 3-hour exposure, so the highest concentration was determined by the solubility in the culture medium. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone; acetone
- Justification for choice of solvent/vehicle: none given in report. Acetone is a well-established solvent mentioned in the OECD Test Guideline.
- Justification for percentage of solvent in the final culture medium: none given in report. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: single. The solvent control was tested in duplicate
- Number of independent experiments : two experiments were reported: an initial 3-hour exposure experiment with metabolic activation and a 24-hour exposure experiment without metabolic activation.
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): 8 x 106 cells (106 cells/mL for 3 hour treatment) or 6 x 10E06 cells (1.25 x 10E05 cells/mL for 24 hour treatment)
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 3-hours and 24-hours
- Expression time (cells in growth medium between treatment and selection): 2 days
- Selection time (if incubation with a selective agent): 11 or 12 days
- Fixation time (start of exposure up to fixation or harvest of cells):
- Method used: microwell plates were used for the mouse lymphoma assay.
- If a selective agent is used (e.g., 6-thioguanine or trifluorothymidine), indicate its identity, its concentration and, duration and period of cell exposure: 5 μg/mL trifluorothymidine for 11 or 12 days.
- Number of cells seeded and method to enumerate numbers of viable and mutants cells: one cell per well in non-selective medium for determination of cloning efficiency. To determine mutant frequency, 9.6 x 10E05 cells per concentration were plated in five 96-well microtiter plates, each well containing 2000 cells in selective medium (TFT-selection). After incubation of 11 or 12 days, the selective plates were stained for 1.5-2 hours with 0.5 mg/mL 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide. Plates for cloning efficiency and mutant frequency were scored with the naked eye or using a microscope.
- Criteria for small (slow growing) and large (fast growing) colonies: small colonies: morphologically dense colonies with a sharp contour and with a diameter less than a quarter of a well. Large colonies: morphologically less dense colonies with a hazy contour and with a diameter larger than a quarter of a well. Wells with two large colonies or one large and one small colony were counted as one large colony. Wells with two small colonies were counted as one small colony.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: cloning efficiency; relative suspension growth (RSG), relative total growth (RTG)
METHODS FOR MEASUREMENTS OF GENOTOXICIY
- OTHER: The mutant frequency was expressed as the number of mutants per 10E06 viable cells. Small and large colony mutation frequencies were calculated in an identical manner. - Rationale for test conditions:
- Standard test conditions
- Evaluation criteria:
- The global evaluation factor (GEF) has been defined by the IWGT as the mean of the negative/solvent MF distribution plus one standard deviation. For the micro well version of the assay the GEF is 126.
A test item is considered positive (mutagenic) in the mutation assay if it induces a MF of more than MF(controls) + 126 in a dose-dependent manner. An observed increase should be biologically relevant and will be compared with the historical control data range.
A test item is considered equivocal (questionable) in the mutation assay if no clear conclusion for positive or negative result can be made after an additional confirmation study.
A test item is considered negative (not mutagenic) in the mutation assay if: none of the tested concentrations reaches a mutant frequency of MF(controls) + 126. - Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- 3-hour exposure
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- 24-hour exposure
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The RTG was reduced to 14%.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: 7.402 at 4.9 μg/mL
- Data on osmolality: 0.347 Osm/kg at 4.9 μg/mL
- Possibility of evaporation from medium: vapour pressure is low
- Water solubility: the test substance was reported to be difficult to dissolve in aqueous solutions
- Precipitation and time of the determination: After 3 hours, the test item precipitated in the test system at concentrations of 600 μg/mL and above. After 24 hours, the test item precipitated in the test system at concentrations of 50 and/or 100 μg/mL and above.
RANGE-FINDING/SCREENING STUDIES (if applicable): a range finding study was conducted using 100 μg/mL test material in acetone. Cells were exposed for 3 hours with and without metabolic activation and for 24 hours without metabolic activation. Surviving cells of the 3-hour treatment were subcultured twice before counting, those of the 24-hour treatment were subcultured once. The suspension growth expressed as the reduction in cell growth after approximately 24 and 48 hours or only 24 hours cell growth, compared to the cell growth of the solvent control, was used to determine an appropriate dose-range for the mutagenicity tests.
STUDY RESULTS
- Concurrent vehicle negative and positive control data:
For all test methods and criteria for data analysis and interpretation:
- Statistical analysis; p-value if any : none
- Any other criteria: global evaluation factor (GEF): 126
Gene mutation tests in mammalian cells:
- Results from cytotoxicity measurements:
o Relative total growth (RTG) or relative survival (RS) and cloning efficiency RTF
- Genotoxicity results:
o Number of cells treated and sub-cultures for each cultures : acceptable
o Number of cells plated in selective and non-selective medium: acceptable
o Number of colonies in non-selective medium and number of resistant colonies in selective medium, and related mutant frequency: acceptable
o When using the thymidine kinase gene on L5178Y cells: colony sizing for the negative and positive controls: results acceptable - see attached tables and if the test chemical is positive, and related mutant frequency. For the MLA, the GEF evaluation: no test item exceeded the GEF. The numbers of small and large colonies in the test item treated cultures were comparable to the numbers of small and large colonies of the solvent controls.
HISTORICAL CONTROL DATA (with ranges, means and standard deviation, and 95% control limits for the distribution as well as the number of data)
- Positive historical control data: see attached table
- Negative (solvent/vehicle) historical control data: see attached table - Conclusions:
- Di-tert-nonyl polysulfide has been tested for mutagenicity to mammalian cells in a study conducted according to OECD TG 476 and in compliance with GLP. Mouse lymphoma L5178Y TK+/- cells were exposed to test substance for 3 hours at concentrations of up to 600 μg/mL in the presence and absence of metabolic activation. The experiment was repeated with a 24-hour exposure time at concentrations up to 50 μg/mL, at which concentration the Relative Total Growth (RTG) was reduced to 14%. Solvent and positive controls gave expected results No biologically relevant increase in mutant frequency was observed with the test item in the presence or absence of metabolic activation so it was concluded that di-tert-nonyl polysulfide is not mutagenic to mammalian cells under the conditions of the study
Referenceopen allclose all
Experiment 1: treatment in the absence and presence of S-9
S-9 |
Treatment + recovery (hours) |
Vehicle Control |
Concentration (µg/mL) |
Positive Control |
- |
3 + 17 |
DMF |
122.5, 175, 250 |
NQO, 2.5.µg/mL |
+ (Aroclor 1254 induced S-9) |
3 + 17 |
DMF |
122.5, 175, 250 |
CPA, 25 µg/mL |
Experiment 2: treatment in the absence of S-9
S-9 |
Treatment + recovery (hours) |
Vehicle Control |
Concentration (µg/mL) |
Positive Control |
- |
20 + 0 |
DMF |
122.5, 175, 250 |
NQO, 2.5.µg/mL |
+ |
3 + 17 |
DMF |
122.5, 175, 250 |
CPA, 25 µg/mL |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In Vitro Gene Mutation in Bacteria:
One key study was identified to evaluate the in vitro gene mutation potential of di-tert-nonyl polysulfide in bacteria.
In a key reverse gene mutation assay in bacteria (Dawkes, 1998; Klimisch score = 1), the strains TA98, TA100, TA1535, TA1537 and TA102 of S. typhimurium were exposed to di-tert-nonyl polysulfide (TPS 37) in DMF at concentrations of 8, 40, 200, 1000, and 5000 µg/plate in the presence and absence of mammalian metabolic activation using the Ames test. TPS 37 was tested up to limit concentrations of 5000 µg/plate. Following treatment in experiment 1, evidence of toxicity was observed at the highest dose (5000 µg/plate) tested in a few test strains of S. typhimurium. Precipitation of the test material was observed on all plates at concentrations of 1000 and 5000 µg/plate. For experiment 2, dose intervals were narrowed to more closely investigate concentrations of TPS 37 most likely to induce mutagenic response. All treatments in the presence of S-9 employed a pre-incubation step. Evidence of toxicity was found in the higher test doses in the presence and absence of S-9 mix. Precipitation of test agent was observed on all plates at concentrations of 1250 and 5000 µg/plate.
Treatment with TPS 37 did not produce an increase in revertant numbers high enough to be considered characteristic of mutagenic activity in any of the strains tested. Under the conditions of this study, TPS 37 did not induce mutation in five strains of S. typhimurium in the presence or absence of metabolic activation and was therefore considered to be negative in the bacterial reverse mutation test.
Supporting studies are available for the structural analogue substances di-tert-dodecyl polysulfide and di-tert-butyl polysulfide.
An in vitro reverse mutation assay in bacteria with the test substance di-tert-dodecyl polysulfide was conducted in a similar way to OECD TG 471 and in compliance with GLP. The strains S. typhimurium TA 98, 100, 1535, 1537 and 1538 was utilised with and without metabolic activation. No reversion rates were altered in any of the test strains and was therefore concluded as not mutagenic (Jones et al., 1986).
In an in vitro gene mutation in mammalian cells which was conducted according to OECD TG 471 and in compliance with GLP, di-tert-butyl polysulfide was tested by Ames test using five different strains of the bacteria Salmonella typhimurium TA 98, 100, 1535, 1537 and 1538. No mutagenic activity was evident regardless if metabolic activation was present or absent (Molinier, 1992).
In Vitro Cytogenicity in Mammalian Cells:
One key study was identified to evaluate the in vitro cytogenicity potential of di-tert-nonyl polysulfide in mammalian cells.
In a key chromosome aberration study (Burman, 1998; Klimisch score = 1), human lymphocyte cultures from female donors were exposed to TPS 37 in dimethyl formamide (DMF) at concentrations of 122.5, 175, and 250 µg/mL in the presence and absence of mammalian metabolic activation (S-9 mix) for up to 20 hours. TPS 37 was tested up to concentrations of 250 µg/mL. Cultures treated with TPS 37 in the absence and presence of S-9 exhibited frequencies of cells with structural aberrations which were similar to levels seen in concurrent negative controls. One culture treated with 122.5 µg/mL for 20 hours in the absence of S-9 displayed frequencies of cells with structural aberrations that exceeded the normal range for negative controls. A replication did not produce similar results so the effect was not considered biologically relevant. All other tests exhibited frequencies of cells that were within the normal range.
It was therefore concluded that TPS 37 did not induce chromosome aberrations in cultured human peripheral blood lymphocytes when tested in the presence and absence of S-9 mix.
Supporting studies are available for in vitro chromosome aberration test with human lymphocytes, with the structural analogue substances di-tert-dodecyl polysulfide and di-tert-butyl polysulfide. Both studies were conducted according to OECD TG 473 and in compliance with GLP. Neither of the studies evidenced any significant increase of aberrant cells frequency, regardless of presence or absence of metabolic activation (Molinier, 1994 & de Jouffrey, 1996).
In Vitro Gene Mutation in Mammalian Cells
A study has been conducted to evaluate the in vitro gene mutation potential of di-tert-nonyl polysulfide in mammalian cells.
The key in vitro gene mutation study in mammalian cells study with the substance di-tert-nonyl polysulfide was conducted according to OECD TG 490 and in compliance with GLP. Mouse lymphoma L5178Y TK+/- cells were exposed to TPS 37 for 3 hours at concentrations of up to 600 μg/mL in the presence and absence of metabolic activation. The experiment was repeated with a 24-hour exposure time at concentrations up to 50 μg/mL, at which concentration the Relative Total Growth (RTG) was reduced to 14%. Solvent and positive controls gave expected results. No biologically relevant increase in mutant frequency was observed with the test item in the presence or absence of metabolic activation so it was concluded that di-tert-nonyl polysulfide is not mutagenic to mammalian cells under the conditions of the study (Charles River Laboratories, 2021).
Justification for classification or non-classification
Based on the available in vitro mutation and cytogenetic data and in vivo micronucleus assays, di-tert-nonyl polysulfides does not meet the criteria for classification under CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
